Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Yu, Saida"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/45f478dcf2244630b3d358e1c082590f
Autor:
Kazutoshi Yamamoto, Ana Opina, Deepak Sail, Burchelle Blackman, Keita Saito, Jeffrey R. Brender, Ronja M. Malinowski, Tomohiro Seki, Nobu Oshima, Daniel R. Crooks, Shun Kishimoto, Yu Saida, Yasunori Otowa, Peter L. Choyke, Jan H. Ardenkjær-Larsen, James B. Mitchell, W. Marston Linehan, Rolf E. Swenson, Murali C. Krishna
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Drastic sensitivity enhancement of dynamic nuclear polarization is becoming an increasingly critical methodology to monitor real-time metabolic and physiological information in chemistry, biochemistry, and biomedicine. However, the limited n
Externí odkaz:
https://doaj.org/article/bad8b5268826453db750b84fe20d286f
Autor:
Tomohiro Seki, Yu Saida, Shun Kishimoto, Jisook Lee, Yasunori Otowa, Kazutoshi Yamamoto, Gadisetti VR Chandramouli, Nallathamby Devasahayam, James B. Mitchell, Murali C. Krishna, Jeffery R. Brender
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 30, Iss , Pp 100793- (2022)
Purpose: PEGylated human hyaluronidase (PEGPH20) enzymatically depletes hyaluronan, an important component of the extracellular matrix, increasing the delivery of therapeutic molecules. Combinations of chemotherapy and PEGPH20, however, have been uns
Externí odkaz:
https://doaj.org/article/f1585e36c7944ba19758e09803a3851d
Autor:
Yu Saida, Satoshi Watanabe, Tetsuya Abe, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Kenichi Koyama, Satoru Miura, Hiroshi Tanaka, Masaaki Okajima, Masaki Terada, Takashi Ishida, Hiroki Tsukada, Masato Makino, Akira Iwashima, Kazuhiro Sato, Naoya Matsumoto, Hirohisa Yoshizawa, Toshiaki Kikuchi
Publikováno v:
Thoracic Cancer, Vol 10, Iss 11, Pp 2106-2116 (2019)
Background Although the clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) in EGFR‐mutant non‐small cell lung cancer (NSCLC) patients has been demonstrated, their efficacy in EGFR‐mutant NSCLCs with c
Externí odkaz:
https://doaj.org/article/4c3c0980a21a4b178a904cf7dd6b0608
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients
Autor:
Kohei, Kushiro, Satoshi, Watanabe, Yuka, Goto, Toshiya, Fujisaki, Naohiro, Yanagimura, Aya, Ohtsubo, Satoshi, Shoji, Koichiro, Nozaki, Tomohiro, Tanaka, Yu, Saida, Yusuke, Sato, Takeshi, Ota, Jun, Koshio, Yoshiki, Hayashi, Takao, Miyabayashi, Naoya, Matsumoto, Kosuke, Ichikawa, Kenichi, Koyama, Toshiaki, Kikuchi
Publikováno v:
Translational Lung Cancer Research. 11:1858-1865
Although the addition of immune checkpoint inhibitors (ICIs) to platinum-doublet chemotherapy has improved the efficacy of first-line therapy in extensive-disease small cell lung cancer (SCLC) patients, the best treatment option for patients with rec
Autor:
Yasunori Otowa, Shun Kishimoto, Yu Saida, Kota Yamashita, Kazutoshi Yamamoto, Gadisetti VR Chandramouli, Nallathamby Devasahayam, James B. Mitchell, Murali C. Krishna, Jeffery R. Brender
Publikováno v:
Antioxidants & Redox Signaling.
AimsPancreatic ductal adenocarcinomas (PDACs) form hypovascular and hypoxic tumors which are difficult to treat with current chemotherapy regimens. Gemcitabine (GEM) is often used as a first line treatment for PDACs, but has issues with chemoresistan
Autor:
Shun Kishimoto, Murali C. Krishna, James B. Mitchell, Kazutoshi Yamamoto, Jeffrey R. Brender, Yu Saida
Immune checkpoint blockade (ICB) has become a standard therapy for several cancers, however, the response to ICB is inconsistent and a method for noninvasive assessment has not been established to date. To investigate the capability of multimodal ima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f890beee47ec83688d4ea7de001a6aa
https://doi.org/10.1158/0008-5472.c.6513205.v1
https://doi.org/10.1158/0008-5472.c.6513205.v1
Autor:
Shun Kishimoto, Murali C. Krishna, James B. Mitchell, Kazutoshi Yamamoto, Jeffrey R. Brender, Yu Saida
Supplementary Data, including figures 1-6 and tables 1-2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d173ed11731b0ff015363187d66801a4
https://doi.org/10.1158/0008-5472.22428991
https://doi.org/10.1158/0008-5472.22428991
Autor:
Nallathamby Devasahayam, Yu Saida, Murali Krishna Cherukuri, Shun Kishimoto, Jeffrey R. Brender
Publikováno v:
Antioxid Redox Signal
Significance: Oxygen imaging techniques, which can probe the spatiotemporal heterogeneity of tumor oxygenation, could be of significant clinical utility in radiation treatment planning and in evaluating the effectiveness of hypoxia-activated prodrugs
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer
Autor:
Aya Ohtsubo, Miyuki Sato, Toshiyuki Koya, Masashi Arita, Satoshi Shoji, Satoshi Hokari, Satoshi Watanabe, Ko Sato, Nobumasa Aoki, Toshiya Fujisaki, Ryo Suzuki, Toshiaki Kikuchi, Kosuke Ichikawa, Miho Takahashi, Yuki Sekiya, Yuko Abe, Masachika Hayashi, Yasuyoshi Ohshima, Koichiro Nozaki, Rie Kondo, Yu Saida
Publikováno v:
Cancer Immunology, Immunotherapy. 71:1357-1369
Lymphodepleting cytotoxic regimens enhance the antitumor effects of adoptively transferred effector and naive T cells. Although the mechanisms of antitumor immunity augmentation by lymphodepletion have been intensively investigated, the effects of ly